The Canberra Centre Sandor Earl doping scandal refers to the controversy surrounding Australian rugby league player Sandor Earl, who was banned from the sport for four years after testing positive for banned substances in 2013.
Earl was playing for the Canberra Raiders at the time of the incident, and he was suspended from the sport by the National Rugby League (NRL) in August 2013 after testing positive for a range of prohibited substances, including CJC-1295. Earl admitted to the use of the peptide, which is not approved for human use in Australia and is classified as a banned substance by the World Anti-Doping Agency (WADA).
Earl cooperated with authorities during the investigation into the incident and received a reduced penalty of four years rather than the maximum penalty of life ban. He returned to playing rugby league in 2017 after serving his suspension and signing with the Melbourne Storm.
The incident prompted increased scrutiny of the use of peptides and other performance-enhancing drugs in Australian rugby league, as well as calls for stronger anti-doping measures and better education for athletes on the risks and consequences of using banned substances.
Use of peptides is on the rise. With that in mind let us discuss this one.
What is CJC-1295?
CJC-1295 is a synthetic peptide that works by increasing the production of growth hormone-releasing hormone (GHRH) in the body. GHRH, in turn, stimulates the release of growth hormone (GH) from the pituitary gland.
Growth hormone plays an important role in muscle growth and development. When released into the bloodstream, GH stimulates the production of insulin-like growth factor 1 (IGF-1), which is a critical factor in muscle growth and development. IGF-1 stimulates the differentiation and proliferation of satellite cells, which are muscle stem cells that play a crucial role in muscle growth and repair.
CJC-1295 works by increasing the levels of GH and IGF-1 in the body, which can lead to an increase in muscle mass and strength. Research has suggested that CJC-1295 can stimulate muscle growth in both young and old subjects. For example, a study published in the Journal of Clinical Endocrinology and Metabolism found that CJC-1295 increased muscle mass and strength in healthy young men. Another study published in the Journal of Endocrinology and Metabolism found that CJC-1295 improved muscle growth and strength in older adults.
It’s important to note that CJC-1295 is intended for research purposes only and has not been approved for human use by regulatory agencies such as the FDA. As such, it is important to exercise caution and consult with a qualified medical professional before considering the use of any research peptide.
What are the benefits of CJC-1295?
- Increased muscle mass and strength: CJC-1295 works by increasing the levels of growth hormone-releasing hormone (GHRH) in the body, which in turn stimulates the release of growth hormone (GH) from the pituitary gland. GH plays an important role in muscle growth and development, and CJC-1295 may help increase muscle mass and strength.
- Improved bone density: GH and insulin-like growth factor 1 (IGF-1), which is stimulated by GH, play important roles in bone health. CJC-1295 may help improve bone density by increasing levels of GH and IGF-1.
- Improved immune function: GH has been shown to have immune-stimulating effects, and CJC-1295 may help boost immune function.
- Increased fat loss: GH has been shown to have fat-burning effects, and CJC-1295 may help increase fat loss by increasing GH levels.
- Improved sleep: GH is known to play a role in sleep regulation, and CJC-1295 may help improve sleep quality.
How is CJC-1295 generally taken?
CJC-1295 is typically taken as an injection, which is administered subcutaneously (under the skin) or intramuscularly (into the muscle). The injection site can vary, but commonly used injection sites include the abdomen, thighs, and buttocks.
The dosage of CJC-1295 can vary depending on the individual and the intended use. Research suggests that a typical dosage for CJC-1295 is between 30-60 micrograms per kilogram of body weight per injection, administered one to two times per week. However, it’s important to note that the dosage and frequency of use may vary based on individual needs and the advice of a qualified medical professional.
CJC-1295 has a relatively long half-life, meaning that it remains active in the body for an extended period of time. This may allow for less frequent dosing compared to other peptides.
It’s important to note that CJC-1295 is intended for research purposes only and has not been approved for human use by regulatory agencies such as the FDA. As such, it is important to exercise caution and consult with a qualified medical professional before considering the use of any research peptide. Additionally, proper handling, storage, and disposal of the peptide is important to ensure safety and efficacy.
If you are not an athlete and want to build muscle considering learning more below:
